The extra week inside the quarter

Medtronic closed the quarter ended 31 July with 9.756 billion dollars of revenue, and reported the increase as 13.7 per cent on both a reported and an organic basis. The same release puts the contribution of the extra fiscal week to organic growth at about 570 million dollars. A material part of the headline rate is produced as much by the calendar as by demand.[1]

The definition of organic growth is what decides the question. In building the measure the company strips out revenue from the divested Dutch obesity clinic, the 14 million dollars and 5 million dollars contributed by the Scientia and SPR Therapeutics acquisitions, and a currency benefit of 57 million dollars, but it does not strip out the extra week. Each excluded item sits far below 570 million dollars.[1]

What the margin says

Revenue rose 13.7 per cent while the non-GAAP operating margin widened by only 10 basis points to 23.7 per cent. The GAAP operating margin gained 120 basis points to 18.1 per cent. Read together, the two numbers leave almost no operating leverage visible in the adjusted picture, and the improvement sits mostly in the shrinking of the items adjusted out on the GAAP side.[1]

The same spread stands in earnings per share. GAAP diluted earnings rose 40.7 per cent to 1.14 dollars and the non-GAAP figure rose 15.1 per cent to 1.45 dollars. An adjusted measure growing more slowly than the reported one points to last year's adjustments being larger than this year's; the alternative reading is that tax and financing lines lifted the GAAP side disproportionately.[1]

What the guidance measures

The quarter came in roughly 200 basis points above the company's own guidance midpoint. Against that, full-year organic revenue growth guidance moved up 50 basis points, from 6.75–7.25 per cent to 7.25–7.75 per cent. The bottom of the non-GAAP earnings per share range moved from 5.90 dollars to 5.94 dollars, and the top was left at 6.00 dollars.[1]

The asymmetry in the guidance fits reading the extra week as a timing effect. Revenue that arrives from the calendar does not repeat later in the year, so it does not lift full-year earnings by the same amount. The signal to watch is plain: without an extra week, does second-quarter organic growth land inside the new 7.25–7.75 per cent range?[1]